Samrat Pharmachem Ltd.

BSE: 530125

Strong Performer, Under Radar

Download real time

335.00 14.45 (4.51%)

New 52W Low in past week

3,829 BSE Volume

BSE 11 Apr, 2025 1:22 PM (IST)

103.5

Market Cap

Below industry Median

0.7

Beta 1Year

Very Low volatility

Samrat Pharmachem Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Samrat Pharmachem Ltd. on BSE

Load latest

Samrat Pharmachem Ltd.

18 Apr 2024

335.00

4.51%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations …

BSE India

Compliance Certificate u/r 40(9) of SEBI (LODR), Regulations, 2015 for the period: 01-04-2023 To 31-03-2024.

Samrat Pharmachem Ltd.

10 Apr 2024, 03:49PM

335.00

4.51%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Compliance Certificate Under Regulation 7(3) For The Period: 01St April …

BSE India

Compliance Certificate under regulation 7(3) for the period 1st April, 2023 to 31st March, 2024

Samrat Pharmachem Ltd.

10 Apr 2024, 03:35PM

335.00

4.51%

AGM

SAMRAT PHARMACHEM LTD.-$ - 530125 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Outcome of postal ballot remote e-voting & scrutinizer report

Samrat Pharmachem Ltd.

10 Apr 2024, 03:32PM

335.00

4.51%

AGM

SAMRAT PHARMACHEM LTD.-$ - 530125 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

BSE India

Voting Results of the Postal Ballot activity through remote e-voting and the Report of Scrutinizer

Samrat Pharmachem Ltd.

08 Apr 2024

335.00

4.51%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg. 74(5) for the quarter ended March 31, 2024.

Samrat Pharmachem Ltd.

28 Mar 2024

335.00

4.51%

Board Meeting

SAMRAT PHARMACHEM LTD.-$ - 530125 - Board Meeting Intimation for Notice Of Board Meeting For Audited …

BSE India

SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve the Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2024. The Board of Directors may consider a proposal to recommend dividend on the equity shares of the company for the financial year ended March 31, 2024.

Samrat Pharmachem Ltd.

28 Mar 2024

335.00

4.51%

SAST

SAMRAT PHARMACHEM LTD.-$ - 530125 - Closure of Trading Window

BSE India

The Trading Window of the company shall remain closed from Monday, April 1, 2024 till 48 hours after the declaration of Audited Financial Results for the year ended 31st March, 2024 for all Designated persons including their immediate relatives.

Samrat Pharmachem Ltd.

05 Mar 2024

335.00

4.51%

AGM

SAMRAT PHARMACHEM LTD.-$ - 530125 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Postal Ballot Notice with Explanatory Statement

Samrat Pharmachem Ltd.

29 Feb 2024

335.00

4.51%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Credit Rating issued by CRISIL

Samrat Pharmachem Ltd.

21 Feb 2024

335.00

4.51%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Publication of Extract of Standalone Un-audited Financial Results for the quarter ended December 31, 2023

No results found

Is Samrat Pharmachem Ltd. worth buying?

45 Votes:

Buy 66.67%

Sell 13.33%

Hold 20.0%